Joanna Horobin is of Kymera Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KYMR, which is worth approximately $0. The most recent transaction as insider was on Jun 07, 2024, when has been sold 8,500 shares (Common Stock) at a price of $32.88 per share, resulting in proceeds of $279,480. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Joanna Horobin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2024
SELL
Open market or private sale
$279,480 $32.88 p/Share
8,500 Reduced 100.0%
0 Common Stock
Jun 07 2024
BUY
Exercise of conversion of derivative security
$17,680 $2.08 p/Share
8,500 Added 50.0%
8,500 Common Stock

Also insider at

LQDA
Liquidia Corp Healthcare
VYNT
Vyant Bio, Inc. Healthcare
JH

Joanna Horobin

Cherry Hill,, NJ

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR